Maria Frank-Kamenetsky

USPTO Granted Patents = 38 (Patent Applications = 15)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 16)

Average Co-Inventor Count = 6.0

ph-index = 11

Forward Citations = 763(Granted Patents)

Company Filing History:

30 out of 444

Alnylam Pharmaceuticals, Inc.

Wave Life Sciences Ltd.

patents

4. 1 out of 14

Tekmira Pharmaceuticals Corporation

patents

5. 1 out of 57

Arbutus Biopharma Corporation

patents

Years Active: 2006-2025

Loading Chart...

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12467051 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2025-11-11),

2. 12460206 - PCSK9 iRNA compositions and methods of use thereof (2025-11-04),

3. 11866709 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2024-01-09),

4. 11840692 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2023-12-12),

5. 11834662 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2023-12-05),

6. 11634710 - Oligonucleotide compositions and methods thereof (2023-04-25),

7. 11603532 - Oligonucleotide compositions and methods of use thereof (2023-03-14),

8. 11525138 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2022-12-13),

9. 11332743 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2022-05-17),

10. 11306316 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2022-04-19),

11. 11306315 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2022-04-19),

12. 11306314 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2022-04-19),

13. 11130953 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2021-09-28),

14. 10934545 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2021-03-02),

15. 10557139 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2020-02-11),

Title: Maria Frank-Kamenetsky: Pioneering Inventor in Genetic Therapies

Introduction:

Maria Frank-Kamenetsky, based in Brookline, MA, is a trailblazing inventor known for her significant contributions to genetic therapies. With an impressive portfolio of 36 patents, Maria's innovative work has paved the way for advancements in treating lipid metabolism disorders.

Latest Patents:

Among Maria's latest patents is the groundbreaking invention titled "Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof." This invention focuses on utilizing double-stranded ribonucleic acid (dsRNA) compositions to target the ANGPTL3 gene. The methods outlined in the patent aim to inhibit the expression of ANGPTL3, offering promising treatment avenues for individuals with lipid metabolism disorders such as hyperlipidemia and hypertriglyceridemia.

Career Highlights:

Maria Frank-Kamenetsky has made significant strides in the biopharmaceutical industry, collaborating with leading companies to bring innovative genetic therapies to the forefront. She has notably contributed her expertise to companies like Alnylam Pharmaceuticals, Inc. and Curis, Inc., playing a pivotal role in driving research and development efforts in the field of genetic medicine.

Collaborations:

Throughout her career, Maria has collaborated closely with esteemed professionals in the industry, including coworkers like Kevin Fitzgerald and William Querbes. These collaborations have not only strengthened her innovative approach to genetic therapies but have also fostered a collaborative spirit within the research community.

Conclusion:

In conclusion, Maria Frank-Kamenetsky stands as a visionary inventor whose pioneering work in genetic therapies has reshaped the landscape of modern medicine. With a keen focus on advancing treatment options for lipid metabolism disorders, Maria's patents and collaborations underscore her commitment to driving innovation and improving patient outcomes in the field of biopharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.